NGEN is NervGen Pharma Corp. (Healthcare) — a non-dividend-paying stock. Trading at $2.33. Market cap: $249M.
Stock snapshot
| Price | $2.33 |
| Market cap | $249M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About NGEN
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
Related non-dividend companies
Other non-dividend stocks investors research alongside NGEN. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is NGEN's current stock price?
NGEN (NervGen Pharma Corp.) is currently trading at $2.33.
Does NGEN pay a dividend?
NGEN (NervGen Pharma Corp.) does not currently pay a regular dividend.
Track NGEN in DiviDrip
Add NGEN to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search NGEN and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.